Please login to the form below

Not currently logged in
Email:
Password:

Corin Baird joins Havas Just:: as head of digital

Baird joins the team with a varied background in digital marketing

Havas Just:: has appointed Corin Baird (pictured above) as head of digital to underpin its medcomms and PR divisions.

Baird joins the team with a varied background in digital marketing, with his previous roles including head of creative solutions at Buzzfeed, Huffington Post and The Guardian. He has also served in a number of leadership roles at agencies Nitro and Sudler.

“We were looking for someone who understands how to design content that has an impact.  Corin’s experience of creating digital content to generate a direct commercial gain means that he is driven by efficiency and return on investment," said Nicole Yost, chief executive officer of Havas Just::

"These principles are equally important in healthcare communications when your goal may be HCP education or patient behaviour change," she added,

Baird is supported in his new role by Florence Chinn, who permanently joined Havas Just:: in April. Previously, Chinn worked as digital communications manager for AbbVie in the UK.

Article by
Lucy Parsons

29th April 2021

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
fox&cat

up to your ears in it? some pressure is helpful but too much of the wrong sort quickly takes its...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....